(Q42602749)

3 November 2017

title

Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy (English)

1 reference

3 November 2017

1 reference

1 reference

Martha J Morrell

1

1 reference

3 November 2017

Jouko Isojärvi

2

1 reference

3 November 2017

Ann E Taylor

3

1 reference

3 November 2017

Mogens Dam

4

1 reference

3 November 2017

Ricardo Ayala

5

1 reference

3 November 2017

Gema Gomez

6

1 reference

3 November 2017

Fiona O'Neill

7

1 reference

3 November 2017

Pat Tennis

8

1 reference

3 November 2017

John Messenheimer

9

1 reference

3 November 2017

publication date

1 May 2003

1 reference

3 November 2017

1 reference

3 November 2017

volume

54

1 reference

3 November 2017

issue

2-3

1 reference

3 November 2017

page(s)

189-199

1 reference

Reproductive endocrine disorders in women with primary generalized epilepsy

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Weight gain in epileptic patients during treatment with valproic acid: a retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Ovulatory Function in Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Stable weight during lamotrigine therapy: a review of 32 studies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Obesity and its effect on reproductive function

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Epidemiology of menstruation and its relevance to women's health

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Temporal lobe epilepsy: an extrahypothalamic pathogenesis for polycystic ovarian syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Reproductive endocrine disorders in women with partial seizures of temporal lobe origin.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Obesity and endocrine disorders in women taking valproate for epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Altered ovarian function and cardiovascular risk factors in valproate-treated women

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

The importance of diagnosing the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

1 reference

7 January 2021

Reduced fertility and neuroendocrine dysfunction in women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Obesity, insulin, sex steroids and ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2803%2900085-8

7 January 2021

10.1016/S0920-1211(03)00085-8

Identifiers

DOI

1 reference

3 November 2017

1 reference